Livostin Nasenspray, Suspension

7680504970110 CH-50497 suspension
Livostin Nasenspray, Suspension
Livostin Nasenspray, Suspension
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/04/2025
Patient information leaflet
Français
28/04/2025
Patient information leaflet
Italien
28/04/2025
Summary of Product Characteristics
Allemand
28/04/2025
Summary of Product Characteristics
Français
28/04/2025
Summary of Product Characteristics
Italien
28/04/2025

Detailed composition

Substance Quantity Type Category
levocabastinum
0.5 MG Substance Wirkstoff (Principe actif)
levocabastini hydrochloridum
- Substance WIZUS
levocabastinum
0.05 MG Substance Wirkstoff (Principe actif)
dinatrii phosphas
- Substance HNIDK
natrii dihydrogenophosphas monohydricus
- Substance HNIDK
hypromellosum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
benzalkonii chloridum
0.15 MG Substance Konservierungsstoff (Conservateur)
aqua purificata
- Substance HNIDK

Authorization holder

JNTL Consumer Health II

6343 Risch

Authorization information

Swissmedic authorization number
50497
Drug name
Livostin Nasenspray, Suspension
Galenic form
NASSS
ATC Code
R01AC02
Authorization status
Z
Dispensing category
D
First authorization
27/06/1994
Authorization expiration date
31/12/9999
IT Number
12.02.7.
Domain
Human medicine
Field of application
Allergische Rhinitis

Package details

Description (FR)
LIVOSTIN spray nasal 0.05 % fl 10 ml
Description (DE)
LIVOSTIN Nasenspray 0.05 % Fl 10 ml
Market launch
27/06/1994
Narcotic (BTM)
No
Buy us a coffee Explore the data